Gene Biotherapeutics, Inc.
CRXM · OTC
12/31/2020 | 9/30/2020 | 6/30/2020 | 3/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$490 | -$401 | $408 | -$169 |
| Dep. & Amort. | $1 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $220 | -$152 | $37 | $75 |
| Other Non-Cash | -$69 | $73 | -$667 | $0 |
| Operating Cash Flow | -$338 | -$480 | -$221 | -$94 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$3 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$3 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$192 | $12 | $72 | $96 |
| Stock Issued | $600 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $135 | -$60 | $1,459 | $0 |
| Financing Cash Flow | -$58 | -$48 | $1,531 | $96 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$396 | -$531 | $1,310 | $3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $782 | $1,312 | $3 | $0 |
| End Cash | $386 | $782 | $1,312 | $3 |
| Free Cash Flow | -$338 | -$483 | -$221 | -$94 |